Holen Sie sich die Stockscreener-App
2.535
7.14%
-0.1949
Handel nachbörslich:
2.56
0.025
+0.99%
Schlusskurs vom Vortag:
$2.7299
Offen:
$2.7429
24-Stunden-Volumen:
95,035
Relative Volume:
0.54
Marktkapitalisierung:
$95.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.27M
KGV:
-15.46
EPS:
-0.164
Netto-Cashflow:
$-7.70M
1W Leistung:
-7.82%
1M Leistung:
+3.47%
6M Leistung:
+136.92%
1J Leistung:
+102.80%
1-Tages-Spanne:
$2.50
$2.7429
1-Wochen-Bereich:
$2.50
$2.7983
52-Wochen-Spanne:
$0.8075
$3.11
Okyo Pharma Limited Stock (OKYO) Company Profile
Firmenname
Okyo Pharma Limited
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie OKYO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OKYO
Okyo Pharma Limited
|
2.535 | 102.67M | 0 | -13.27M | -7.70M | -0.164 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 118.34B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.14 | 60.31B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.35B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.79 | 36.43B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.74 | 31.87B | 3.81B | -644.79M | -669.77M | -6.24 |
Okyo Pharma Limited Aktie (OKYO) Neueste Nachrichten
Should I hold or sell OKYO Pharma Limited stock in 2025Capitalize on market shifts before others do - jammulinksnews.com
How does OKYO Pharma Limited compare to its industry peersMaximize your returns with expert insights - jammulinksnews.com
Analyzing OKYO Pharma Limited with risk reward ratio chartsFree Growth Based Stock Signal Screener - Newser
What is OKYO Pharma Limited company’s growth strategyAchieve consistent double-digit returns - jammulinksnews.com
What are the latest earnings results for OKYO Pharma LimitedTransform your portfolio with high-yield stocks - jammulinksnews.com
Is it the right time to buy OKYO Pharma Limited stockSky-high profits - jammulinksnews.com
What markets is OKYO Pharma Limited expanding into Is BAYA stock a good long term investment option - jammulinksnews.com
What are OKYO Pharma Limited company’s key revenue driversMaximize gains with proven stock analysis - jammulinksnews.com
What catalysts could drive OKYO Pharma Limited stock higher in 2025Free Stock Selection - jammulinksnews.com
What is the risk reward ratio of investing in OKYO Pharma Limited stockInvest smarter with real-time trading alerts - jammulinksnews.com
Published on: 2025-07-27 19:17:36 - jammulinksnews.com
How Resilient Is OKYO Pharma Limited Stock During Economic DownturnsFast Moving Stock Alerts - Newser
Why OKYO Pharma Limited stock attracts strong analyst attentionMarket Beating Strategy - Newser
How OKYO Pharma Limited stock performs during market volatilityControlled Risk High Reward Plan - Newser
OKYO Pharma Limited Stock Analysis and ForecastMarket-beating returns - PrintWeekIndia
What analysts say about OKYO Pharma Limited stockMassive stock growth - PrintWeekIndia
What institutions are buying OKYO Pharma Limited stock nowFree Market Dynamics Reports - jammulinksnews.com
Will OKYO Pharma Limited stock benefit from AI tech trendsExplosive market performance - jammulinksnews.com
OKYO Pharma reports promising phase 2 results for urcosimod in neuropathic corneal pain - Pharmafile
What drives OKYO Pharma Limited stock priceAccelerated wealth expansion - Autocar Professional
Is OKYO Pharma Limited a good long term investmentPhenomenal trading returns - Autocar Professional
OKYO Pharma Secures $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain - VisionMonday.com
Finanzdaten der Okyo Pharma Limited-Aktie (OKYO)
Umsatz
Nettogewinn
Free Cashflow
ENV
10.28%
2.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):